Life ScienceCompany
Strides Pharma Science M&A Summary
Strides Pharma Science has acquired 2 companies. It has also divested 2 assets.
Strides Pharma Science’s largest acquisition to date was in 2007, when it acquired Grandix Pharmaceuticals for $24M. It’s largest disclosed sale occurred in 2013, when it sold Agila Specialties Pvt. to Viatris for $1.8B. Strides Pharma Science has acquired in 1 US state, and 2 countries. The Company’s most targeted sectors include life science (100%).
Strides Pharma Science Business Overview
Where is Strides Pharma Science headquartered?
Strides Pharma Science is headquartered in Bangalore, India.
What is Strides Pharma Science’s revenue?
Strides Pharma Science disclosed revenue of 40,511M INR for 2024 and 36,884M INR for 2023.
How many employees does Strides Pharma Science have?
Strides Pharma Science has 2,390 employees.
What sector is Strides Pharma Science in?
Strides Pharma Science is a life science company.
When was Strides Pharma Science founded?
Strides Pharma Science was founded in 1990.
M&A Summary
-
M&A Total Activity4
- M&A Buy Activity2
- M&A Sell Activity2
- Total Sectors Invested 1
- Total Countries Invested 2
- M&A Buy/Sell Connections 3
- M&A Advisors 1
Unlimited Searches
